Lipid-lowering APIs are a class of compounds widely used to treat hyperlipidemia is a disease characterized by elevated levels of lipids (such as cholesterol and triglycerides) in the blood. Protheragen provides a full range of lipid-lowering APIs to support global customers' research, including but not limited to statins, fiber acid derivatives, bile acid sequestrants, etc. These APIs play a crucial role in controlling lipid abnormalities and reducing cardiovascular disease risk.